###### Strengths and limitations of this study

-   This study is the first randomised controlled multicentre trial to assess virtual reality (VR) to teach infection prevention and control measures.

-   This study will be performed simultaneously in three European universities

-   Enrolment of medical students on a voluntary basis could introduce a bias because more keen and motivated students or with previous experience in an operating room (OR) could want to enrol.

-   This study will not allow assessing the long-term effect of VR to change medical students behaviours in the OR.

Introduction {#s1}
============

Surgical site infections (SSI) contribute to healthcare-associated infections. The European Centre for Disease Prevention and Control estimated that 799 185 new cases of SSI and 16 049 attributable deaths occur every year in the European Union.[@R1] Many SSIs could be prevented by following adequate infection prevention and control (IPC) measures such as optimal hand hygiene, timely preoperative antimicrobial prophylaxis or minimised circulation of personnel in the operating room (OR).[@R2]

Non-compliance with IPC measures often occurs due to knowledge gaps and insufficient education and training of healthcare professionals or students.[@R4] For medical students, the highly technical OR environment may appear complex. Education and training in IPC measures and adequate behaviours with patients undergoing surgery cannot usually take place in the OR or may be difficult to organise, due to restricted areas and tight or unexpected surgical schedules. This lack of knowledge may lead to limited awareness of basic SSI prevention rules in students and trainees when accessing the OR, possibly compromising patients' safety.[@R5]

Simulation methods are increasingly used in clinical teaching to address some of the challenges mentioned. Simulation centres are set up in medical schools to teach clinical procedures using a variety of approaches, including models, scenarios, video recording and direct feedback/discussion with trainees.[@R6]

Among the methods included in simulation pedagogy, virtual reality (VR) is an emerging and innovative technology which may offer multiple advantages over more traditional approaches for learners and instructors.[@R8] VR presents a large list of advantages which are as follows: autonomous training available 24/7, total traceability, appealing support for learners who are disinterested in traditional training, and adaptable to the profile and level of the learner. Furthermore, the trainees are fully involved in the scenario, providing a 'close to real life' feeling for a better learning process.[@R11] Finally, VR allows the immersion in a reality-like environment that recreate genuine conditions of the clinical environment, including the OR, with people who can talk, move and react to the player's actions. Despite a vast number of applications, this technique is currently mainly employed for teaching complex surgical techniques or rare/urgent situations (massive admission of gunshot victims or control of Ebola outbreak).[@R12]

The aim of this study is to compare VR with conventional teaching as a tool to teach medical students SSI prevention measures and adequate behaviours in the OR.

Methods and analysis {#s2}
====================

Study setting {#s2-1}
-------------

The study will take place in three universities: Grenoble Alpes University, France (3960 medical students from 2018/2019, with 211 in the third year), Imperial College London, UK (2188 medical students from 2018/2019, with 359 in the third year) and University of Heidelberg, Germany (2645 medical students from 2018/2019, with 358 in the third year).

Trial design {#s2-2}
------------

This is a randomised controlled multicentre trial entitled VIP Room (VIrtual reality for the oPerating Room) comparing an educational intervention based on VR simulation with a conventional education strategy. We used the SPIRIT (Standard Protocol Items Recommendations for Interventional Trials) checklist to guide the reporting of our protocol and the TIDieR (Template for Intervention Description and Replication) to guide the reporting of components of our intervention ([table 1](#T1){ref-type="table"}).[@R15]

###### 

Overview of the VIP Room study, as per TIDieR criteria

  TIDieR criteria      Description of intervention and quality control procedures
  -------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Brief name           VIP Room
  Why?                 Medical students lack training and education opportunities about IPC in OR due to organisational constraints. VR offers opportunities to resolve such constraints, as seen in other experiences of VR application to clinical education and training
  What materials?      Ad hoc VR-based simulation of OR environments presenting a formative assessment of student learning via multiple methods
  What procedures?     Participants provided with VR headset where they are immersed in OR simulation, are presented with knowledge and education about IPC and face in-simulation assessments
  Who provided?        VR session led by postdoctoral nurses, pharmacists, physicians and practitioner researchers, experts in education about IPC, and with experience in developing and evaluating electronic tools such as apps, games and VR
  How?                 Delivered via individual VR commercial headset. Planned engagement of 30 to 45 min per session
  Where?               University classrooms
  When and how much?   One to five sessions (depending on the student's progression)
  Tailoring            Standardised scenarios for all participants

IPC, infection prevention and control; OR, operating room; TIDieR, Template for Intervention Description and Replication; VIP Room, VIrtual reality for the oPerating Room; VR, virtual reality.

For each of the three sites, the trial design will include two parallel groups of students (1:1):

-   The first group will be randomised to receive the VR education intervention (30 to 45 min per session, one to five sessions depending on the student's progression). This group will not receive any theory prior to the simulation.

-   The second group will receive the conventional method (a 1-hour standardised slide-based lecture and two real-life videos about hand hygiene and hand gloving in the OR).

The participants will be informed about the study purposes and procedures, and have time for reflection before inclusion. After getting their signed consent, participants from each university will be randomised to both groups during the school year 2019/2020. If students decline to participate, no disadvantages will arise for them.

Student eligibility criteria {#s2-3}
----------------------------

All third-year medical students during the 2019/2020 school year without any contraindication to use VR (epilepsy, vertigo, psychiatric pathology, pregnancy, cardiac pacemaker or defibrillator, coronary cardiac pathology, hearing aid, strabismus and amblyopia) will be eligible to take part in the study. The students will commit to not be under the influence of alcohol, recreational or prescription drugs during the intervention.

Third-year medical students were selected because this population is usually free of the OR environment (no visit to OR as part of their training) and without SSI prevention measures knowledge at this stage.

Intervention {#s2-4}
------------

The intervention is a VR-based scenario where the student is immersed ([figure 1A, B](#F1){ref-type="fig"}). The VR contains two real-life videos about hand hygiene and hand gloving in the OR. They need to use googles to visualise the scenario ([figure 1C](#F1){ref-type="fig"}). The scenario was built beforehand by selecting the 10 most important IPC measures to teach to students the prevention of SSI. The selection of these 10 measures included a review of current recommendations published by the WHO and public health authorities or scientific societies in France, England and Germany, respectively. Infection control practitioners of the three universities performed the review and compared the measures between the three countries. Identical measures between the three countries and those most relevant for medical students were selected.[@R3] The scenarios were developed in local languages according to countries (French, English and German).

![Pictures of the scenario in VR and tests of the scenario with headsets in Grenoble Alpes University. (A and B) Pictures of the scenario. (C) Tests of the scenario with headsets in Grenoble Alpes University. VR, virtual reality.](bmjopen-2020-037299f01){#F1}

The VR scenario includes three different environments: the first environment (E1) takes place in the anaesthesiologist consultation room before the surgery, the second (E2) takes place in the preoperative room, which includes the locker room and the washing room, and the third (E3) takes place in the OR. Each environment presents the participants with different scenes, each of them a mixture of information and then a task for the participant to complete. For instance, participants may be shown a video clip about hand gloving procedures in the OR, and then asked to select the right or wrong answer. During the proceedings, the performance of the students is monitored using different indicators (duration of the session and number of errors). The duration of a session in each environment is 10 to 15 min. The total duration of a session is 30 to 45 min. Different versions of the environment (five maximum) are available. The students are able to choose and/or repeat the session.

The learning outcomes of E1, E2 and E3 as defined by Bloom and Krathwohl[@R21] are described in [table 2](#T2){ref-type="table"}. The VR group receives a feedback by email after the session

###### 

The 10 most important surgery site infection prevention measures chosen in VIP Room study

  Environment                                                                                                                                                                                                                                                                   Description
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  E1: Anaesthesiologist consultation room                                                                                                                                                                                                                                       Preoperative bathing: explain the basic concept of preoperative bathing, illustrate the areas with the highest microbiological load of the human body
  Decolonisation with mupirocin ointment with or without chlorhexidine bodywash for the prevention of *Staphylococcus aureus* infection in nasal carriers: describe the indications for preoperative *S. aureus* decolonisation, describe the decolonisation procedure          
  Optimal timing for preoperative SAP: understand the impact of SAP on SSI development and resistance rates, define the usage of SAP for patients based on the previously learned risk assessment (ie, contamination classes), describe the correct timing of SAP application   
  Hair removal: understand the impact of hair removal before surgery, identify appropriate methods of hair removal                                                                                                                                                              
  E2: Preoperative room                                                                                                                                                                                                                                                         Surgical hand preparation: describe the correct procedure of surgical hand hygiene including steps and time, identify the correct substances for hand hygiene, and demonstrate the correct movement from the washing room to the OR while holding hands up and without touching anything
  E3: OR                                                                                                                                                                                                                                                                        Outfit: chose the correct clothing before entrance in OR, identify the pitfalls of clothing (ie, no wearing of rings, jewellery, artificial nails, watches, coverage of mouthpieces around nose and mouth and coverage of hoods of all hair), describe the correct procedure of gloving
  Guarantee sterility: identify errors of sterility in the OR                                                                                                                                                                                                                   
  Air treatment: understand the importance of airflow in the OR and demonstrate the correct regulation of airflow in the OR                                                                                                                                                     
  Surgical site preparation: identify the correct substances for surgical site disinfection                                                                                                                                                                                     
  Drapes and gowns: identify and describe the correct placing of drapes and gowns on the patient                                                                                                                                                                                

OR, operating room; SAP, surgical antibiotic prophylaxis; SSI, surgical site infection; VIP Room, VIrtual reality for the oPerating Room.

Enhancing the fidelity of delivery and adherence to the intervention {#s2-5}
--------------------------------------------------------------------

Implementation of the intervention is done entirely by local teams. The local site coordinator is the direct link between the centre and the study team, and is in charge of daily study activities. The coordinator leads the implementation of the intervention (awareness and communication of the study, delivery of education intervention, handling of VR goggles, leading VR session, etc.). The fidelity of the intervention is ensured by regular communication between the three study sites to discuss the project in detail, expectations, responsibilities, key elements of the intervention and progress. Any implementation difficulties are collectively discussed, with the aim of finding solutions.

The local coordinator engages with relevant education managers to ensure institutional buy-in and facilitate participant recruitment.

Control conditions {#s2-6}
------------------

As for the intervention group, the control group will receive a conventional teaching. This 1-hour didactic, classroom-based lecture includes the 10 selected SSI measures and two real-life videos about hand hygiene and hand gloving in the OR.

Outcomes {#s2-7}
--------

The main outcome of the study will be the difference between scores obtained at the IPC exam between the first group and the second group. This assessment corresponds to the Kirkpatrick scale level 2.[@R23] The written exam will be the same in the three countries in local language. The exam will include multiple choice questions. The questions have been designed to assess the knowledge of the students taught using the two methods. Questions were created before randomising students.

The secondary outcomes of the study include: the satisfaction and the student's progression for the VR group. The satisfaction will be evaluated with a questionnaire (Kirkpatrick scale level 1). The student's progression will be evaluated by the number of sessions, the length of time that participants spend on each VR environment and session, and the number of errors per sessions by time.

Study timeline {#s2-8}
--------------

The trial schedule of enrolment, interventions and assessments is presented in the [figure 2](#F2){ref-type="fig"}. The study will take place during the 2019/2020 school year.

![Trial schedule of enrolment, interventions, and assessments (as recommended by SPIRIT). IPC, infection prevention and control; SPIRIT, Standard Protocol Items Recommendations for Interventional Trials.](bmjopen-2020-037299f02){#F2}

Sample size {#s2-9}
-----------

Based on previous students' results of 2018/2019 exam in Grenoble Alpes University (student in fourth year of medical school in 2019/2020), we expect a mean of 14.5 points in the control group and a SD of 2.5 points. Our hypothesis is an expected mean difference of 1.5 points between participants exposed to the conventional education method and those exposed to the VR intervention, which gives an expected effect size of 0.6. Therefore, the minimal number of evaluable students required in each study group for a statistical power of 80% at an alpha risk of 5% is 45. To mitigate participant consent withdrawal, recruitment will include 55 students per groups. We want to estimate the mean difference in each university; thus, we will include 55 students per group and per university.

Recruitment {#s2-10}
-----------

We will recruit voluntary students in the three participating universities on the academic year 2019/2020. At each site, the principal investigator of each country will provide an information sheet; special session of information for students will be planned according to their university schedule. The written agreement of participants will be collected. As per sample size, once 110 participants are enrolled in the study per site, we will cease recruitment. At Grenoble Alpes University, students will receive the information sheets during/after the welcome day for third-year students. At Heidelberg University, students will receive the information sheets during/after an infection control lecture. At Imperial College London the study will be advertised on the three campuses via flyers. It will also be disseminated to the CHERSNet (Centre for Higher Education Research and Scholarship) Network due to the focus of the group on developing and using novel educational platforms, and the MERU (Medical Education Research Unit). The local study coordinator will also disseminate information about the study at the end of scheduled classes. In each university, the help of the third-year Student Representative Office to disseminate and market the study will be arranged, as well as the responsible lecturers for year three in medicine.

Assignment of interventions {#s2-11}
---------------------------

### Sequence generation (ie, randomisation) {#s2-11-1}

An identification number will be assigned to students in each university. Students will be randomised in each university to one of the two study groups (ie, VR or lecture) using computer-generated random numbers. As all participants will be included before the start of the study, they will be randomised simultaneously, so there is no need for restriction of the simple randomisation. The only stratification variable is the university.

### Blinding {#s2-11-2}

Participants will be aware of their allocation to one or other study group. The examiner for the IPC exam and the statistician performing the analysis will be blinded to the identification of the group.

Data collection and management {#s2-12}
------------------------------

Sociodemographic characteristics (age and gender) of the participants and previous experience in OR will be collected at the beginning of the study using paper questionnaire. For the VR group, the number of session, the number of errors incurred by the participants per session as well as the time spent on each environment will be collected. At the end of the study, participants allocated to receive the VR intervention will also complete a questionnaire to assess their level of satisfaction to the Kirkpatrick model level 1. The Geneva Emotion Wheel and the System Usability Scale will be used.[@R25]

We will add open-ended questions about the improvement of the scenario and hygiene education in the VR group.

At the end of the year, the score in IPC exam will be collected with the detail of the questions.

Data monitoring, harms and auditing {#s2-13}
-----------------------------------

We do not have a Data Safety and Monitoring Board because we consider that our trial poses minimal risk to participants. We do not plan to conduct any interim analyses for our primary outcome. We do not plan any audits of trial conduct.

We will monitor, however, the proportion of students allocated to the VR intervention group reporting any adverse effects during, or following the use of the VR goggles, including severe fatigue, severe stress/anxiety or headache. We anticipate these effects, if any, to be infrequent and transient, as per the existing literature.

Statistical methods {#s2-14}
-------------------

The data will be analysed first with intention-to-treat analysis and then per protocol for each university. The variables will be described by group. Qualitative variables will be described in numbers and percentages. Quantitative variables will be described by the median and IQR. Student scores in the assessment session will be compared between groups by a Student's t-test. Then, we will do a meta-analysis on original data from these three studies and we will study the interaction between group and centre. The potential benefit of VR may depend on other variables collected; this will be studied by linear regression to analyse the interaction between groups and other covariates (age and gender), using data from all centres. For all tests, we will use two-sided p values, with alpha \<0.05 level of significance. We do not plan any correction for multiple testing. If less than 5% of the scores (the primary outcome) are missing, we will not impute the missing scores. If between 5% and 20% of the scores are missing, we will impute the missing scores by multiple imputation. If more than 20% of the scores are missing, we will not impute the missing scores and will interpret the results with caution. We will not impute any other missing data. Quantitative analyses will be performed with Stata 15 or later.[@R28]

Patient and public involvement {#s2-15}
------------------------------

Representative students were consulted about the design of the study to define the conventional method for the control group. They gave their opinion before the scenario building about suitable VR environment (duration, avatar...). They have motivated their classmates to participate in the study.

Ethics and dissemination {#s3}
========================

Consent, confidentiality and access to data {#s3-1}
-------------------------------------------

The three studies conform to the principles for all medical research (Declaration of Helsinki), respecting the applicable legal precepts regarding the protection of personal data, as well as European regulation and the regulation in each country. This study has been approved by the Medical Education Ethics Committee of the Imperial College London (MEEC1920-172), the Ethical Committee for the Research of Grenoble Alpes University (CER Grenoble Alpes-Avis-2019-099-24-2) and the Ethics Committee of the Medical Faculty of Heidelberg University (S-765/2019).

Participating students will be informed by the co-investigators before the education, using an information letter validated by the relevant research ethics committee in each country.

A code will be attributed to students and data will be anonymised. The correspondence between the code and student will be kept by the investigators. These documents will be stored in a closed cabinet. All electronic data will be maintained in password-protected computers and stored in encrypted form.

Dissemination policy, authorship eligibility and data sharing plans {#s3-2}
-------------------------------------------------------------------

We aim to disseminate our findings regardless of negative or null results. We plan to present the results of this research project at national and international scientific meetings. We aim to publish our results in open-access journals, so they are widely available to interested international audiences. All named authors in the protocol will be offered participation in the final and any subsequent papers. We will not use any professional writing services.

Due to institutional policies, we will not be able to grant public access to the participant-level data set. We may be able to provide a statistical code. Relevant persons responsible for education at the participating universities will be informed of the results.

The development and use of new cognitive education tools may improve the compliance of future surgeons and surgical teams with SSI preventive measures, and promote best practices during surgical procedures.
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